2012
DOI: 10.1016/j.bmcl.2012.02.070
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(7 citation statements)
references
References 28 publications
0
7
0
Order By: Relevance
“…Kimura et al synthesized pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres, based on modification of previously reported potent BACE1 inhibitor KMI-420 [71] (IC 50 = 8.2 nM) (41). Although KMI-420 exhibited potent inhibitory activity, acidic moieties (carboxylic groups) often possess low membrane permeability across the blood--brain barrier.…”
Section: Anti-alzheimer Activitymentioning
confidence: 98%
See 1 more Smart Citation
“…Kimura et al synthesized pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres, based on modification of previously reported potent BACE1 inhibitor KMI-420 [71] (IC 50 = 8.2 nM) (41). Although KMI-420 exhibited potent inhibitory activity, acidic moieties (carboxylic groups) often possess low membrane permeability across the blood--brain barrier.…”
Section: Anti-alzheimer Activitymentioning
confidence: 98%
“…The SAR of this class of compounds showed that the presence of an isoxazole, thiazole ring and 1,2-diphenyl ethanone group is sufficient to afford potent PTP1B inhibitors and even more potent inhibitors obtained by incorporation of an oxadiazole (compound 18). Compound 18 displayed good in vitro potency (K i = 0.3 µM), selectivity, acceptable absorption, distribution, metabolism, and excretion (ADME) and pharmacokinetic properties in mice and showed 36% oral bioavailability [41].…”
Section: Antidiabetic Activitymentioning
confidence: 99%
“…On the other hand, there are a bunch of reports on 1,3,4-oxadiazoles exhibiting various pharmacological activities, such as anti-diabetic [20], antihypertension [21], analgesic [22], antiviral [23], anticonvulsant [24], antifungal [25] antibacterial [26], anticancer [27], anti-glycation [28], anti-inflammatory [29], antimicrobial [30], and ulcerogenic [31]. Compounds containing oxadiazole units such as Nesapidil, Furamizole, and Zibotentan [32] (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…The 1, 8-diazabicyclo[5.4.0]undec-7-ene (DBU) mediated reactions proceeded smoothly under basic conditions to afford isoxazole-5-carboxylate derivatives. It is well known that the isoxazole unit is a key structural motif in a large number of natural products and pharmaceutically active compounds, and, in particular, functionalized isoxazoles, such as isoxazole-5-carboxylate derivatives, have been synthesized and used as potential HIV-1 protease inhibitors, [19] anti-inflammatory, [20] antiviral, [21] antibiotic, [22] antidepressant, [23] and antifungal agents, [24] DGAT1 inhibitors as anti-obesity agents, [25] potent, selective, and metabolically stable PTP1B inhibitors, [26] and show antitubulin [27] activity as antitumor agents. In addition, the isoxazole ring system is a useful synthetic building block.…”
Section: Introductionmentioning
confidence: 99%